About this trial
The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate.
This study is currently recruiting.
There is no cost for visits or study-related exams.
Eligibility criteria
Qualifiers
ASD, as defined by either a gold standard measure for ASD diagnosis, the Autism Diagnostic Observation Schedule (ADOS); the Autism Diagnostic Interview-Revised (ADI-R); and/or a comprehensive assessment that is consistent with ASD, in the opinion of the principal investigator. For those the PI believes a prospective diagnosis of ASD is warranted, a formal diagnostic assessment will be scheduled at screening.
0 years through 17 years 11 months of age
Disqualifiers
History of a significant adverse reaction to a prior blood draw
In females of reproductive age, pregnancy or plans to become pregnant
Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
9
Trial groupsSee each trial group below.
Sponsors and collaborators
Southwest Autism Research & Resource Center
Lead sponsor
State University of New York - Downstate Medical Center
Collaborator